对照组静点低分子右旋糖苷，口服安慰剂胶囊(淀粉)。
Patients in the control group were treated with low molecular dextran and placebo (made with starch).
低分子肝素抗凝、低分子右旋糖苷扩容为其主要的治疗手段。
The main treatment was low molecular weight heparin anticoagulation and low molecular weight dextran expansion.
目的：考察精制红花注射液与右旋糖苷- 40葡萄糖注射液的配伍稳定性。
Objective: To study the compatible stability of Rifine Safflower injection and Dextran 40 Glucose injection.
结论：低分子右旋糖苷不良反应涉及多个系统，应合理应用低分子右旋糖苷，尽量减少不良反应的发生。
Conclusion: the side reaction of low molecule dextran involves several system, so to reduce the side reaction by administration reasonably.
公司和产品介绍：我们主要经营化工医药原料及其中间体，我们目前的主要产品是右旋糖苷铁10％，20％溶液；
We are the leading supplier of pharmaceutical raw materials and intermediates in China. At present we can offer you Iron Dextran 10%, 20% Solution;
公司和产品介绍：我们主要经营化工医药原料及其中间体，我们目前的主要产品是右旋糖苷铁10％，20％溶液；
We are the leading supplier of pharmaceutical raw materials and intermediates in China. At present we can offer you Iron Dextran 10%, 20% Solution;
应用推荐